Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme

This study reports the initial experience at the University of California San Francisco (UCSF) with tumor resection and permanent, low-activity iodine 125 ((125)I) brachytherapy in patients with progressive or recurrent glioblastoma multiforme (GM) and compares these results to those of similar pati...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Larson, David A., Suplica, Jeffrey M., Chang, Susan M., Lamborn, Kathleen R., McDermott, Michael W., Sneed, Penny K., Prados, Michael D., Wara, William M., Nicholas, M. Kelly, Berger, Mitchel S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Duke University Press 2004
Konular:
Clinical Investigations
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC1871978/
https://ncbi.nlm.nih.gov/pubmed/15134626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/S1152851703000425
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller